Terms: = Thyroid cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Treatment
38 results:
1. Insights on hematopoietic cell kinase: An oncogenic player in human cancer.
Luo S; Du S; Tao M; Cao J; Cheng P
Biomed Pharmacother; 2023 Apr; 160():114339. PubMed ID: 36736283
[TBL] [Abstract] [Full Text] [Related]
2. Dsg2-mediated c-Met activation in anaplastic thyroid cancer motility and invasion.
Lee K; Lee SH; Kim W; Lee J; Park JG; Kim JS; Kim JT; Kang YE; Shong M; Lee HJ; Kim JM; Kim WG; Koo BS; Kim KS; Min JK
Endocr Relat Cancer; 2020 Nov; 27(11):601-614. PubMed ID: 33022637
[TBL] [Abstract] [Full Text] [Related]
3. Mechanism of RET gene mediated EGFR signaling pathway on epithelial-mesenchymal transition, proliferation and apoptosis of papillary thyroid carcinoma cells.
Zhao YL; Yuan BQ; Shen GS
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8036-8047. PubMed ID: 32767330
[TBL] [Abstract] [Full Text] [Related]
4. Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer.
Di Desidero T; Orlandi P; Gentile D; Banchi M; Alì G; Kusmic C; Armanetti P; Cayme GJ; Menichetti L; Fontanini G; Francia G; Bocci G
Pharmacol Res; 2020 Aug; 158():104920. PubMed ID: 32461187
[TBL] [Abstract] [Full Text] [Related]
5. Activator of thyroid and retinoid receptor increases sorafenib resistance in hepatocellular carcinoma by facilitating the Warburg effect.
Ma L; Liu W; Xu A; Ji Q; Ma Y; Tai Y; Wang Y; Shen C; Liu Y; Wang T; Han J; Zhao C
Cancer Sci; 2020 Jun; 111(6):2028-2040. PubMed ID: 32279388
[TBL] [Abstract] [Full Text] [Related]
6. PBX3 Promotes Tumor Growth and Angiogenesis via Activation of AT1R/VEGFR2 Pathway in Papillary thyroid Carcinoma.
Chen Q; Yu WY; Zhang HH; Zhang SZ; Fang J; Wu F; Ying HZ; Yu CH
Biomed Res Int; 2020; 2020():8954513. PubMed ID: 32047817
[TBL] [Abstract] [Full Text] [Related]
7. Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer.
Lee WK; Kim WG; Fozzatti L; Park S; Zhao L; Willingham MC; Lonard D; O'Malley BW; Cheng SY
Endocr Relat Cancer; 2020 Apr; 27(4):209-220. PubMed ID: 31977311
[TBL] [Abstract] [Full Text] [Related]
8. Signet ring cell variant of follicular thyroid carcinoma: Report of two cases with focus on morphological, expressional and genetic characteristics.
Hysek M; Jatta K; Stenman A; Darai-Ramqvist E; Zedenius J; Höög A; Juhlin CC
Diagn Pathol; 2019 Nov; 14(1):127. PubMed ID: 31699114
[TBL] [Abstract] [Full Text] [Related]
9. Interplay of fibroblasts with anaplastic tumor cells promotes follicular thyroid cancer progression.
Fozzatti L; Alamino VA; Park S; Giusiano L; Volpini X; Zhao L; Stempin CC; Donadio AC; Cheng SY; Pellizas CG
Sci Rep; 2019 May; 9(1):8028. PubMed ID: 31142771
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological and prognostic significance of SHP2 and Hook1 expression in patients with thyroid carcinoma.
Cao J; Huang YQ; Jiao-Sun ; Lan XB; Ge MH
Hum Pathol; 2018 Nov; 81():105-112. PubMed ID: 29953894
[TBL] [Abstract] [Full Text] [Related]
11. Upregulation of Tyrosine Kinase FYN in Human thyroid Carcinoma: Role in Modulating Tumor Cell Proliferation, Invasion, and Migration.
Zheng J; Li H; Xu D; Zhu H
Cancer Biother Radiopharm; 2017 Nov; 32(9):320-326. PubMed ID: 29140740
[TBL] [Abstract] [Full Text] [Related]
12. thyroid Hormone Controls Breast cancer Cell Movement via Integrin αV/β3/src/FAK/PI3-Kinases.
Flamini MI; Uzair ID; Pennacchio GE; Neira FJ; Mondaca JM; Cuello-Carrión FD; Jahn GA; Simoncini T; Sanchez AM
Horm Cancer; 2017 Feb; 8(1):16-27. PubMed ID: 28050799
[TBL] [Abstract] [Full Text] [Related]
13. Identification of Differentially Expressed Kinase and Screening Potential Anticancer Drugs in Papillary thyroid Carcinoma.
Zhang H; Gao B; Shi B
Dis Markers; 2016; 2016():2832980. PubMed ID: 27703281
[No Abstract] [Full Text] [Related]
14. The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the src Inhibitor Dasatinib in thyroid cancer.
Beadnell TC; Mishall KM; Zhou Q; Riffert SM; Wuensch KE; Kessler BE; Corpuz ML; Jing X; Kim J; Wang G; Tan AC; Schweppe RE
Mol Cancer Ther; 2016 Aug; 15(8):1952-63. PubMed ID: 27222538
[TBL] [Abstract] [Full Text] [Related]
15. Naringin suppresses the metabolism of A375 cells by inhibiting the phosphorylation of c-src.
Guo B; Zhang Y; Hui Q; Wang H; Tao K
Tumour Biol; 2016 Mar; 37(3):3841-50. PubMed ID: 26476533
[TBL] [Abstract] [Full Text] [Related]
16. Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on thyroid cancer.
Ferrari SM; La Motta C; Sartini S; Baldini E; Materazzi G; Politti U; Ruffilli I; Ulisse S; Miccoli P; Antonelli A; Fallahi P
Mini Rev Med Chem; 2016; 16(2):86-93. PubMed ID: 26471970
[TBL] [Abstract] [Full Text] [Related]
17. TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and src/FAK pathways.
Baquero P; Jiménez-Mora E; Santos A; Lasa M; Chiloeches A
Mol Carcinog; 2016 Nov; 55(11):1639-1654. PubMed ID: 26392228
[TBL] [Abstract] [Full Text] [Related]
18. src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors.
Roskoski R
Pharmacol Res; 2015 Apr; 94():9-25. PubMed ID: 25662515
[TBL] [Abstract] [Full Text] [Related]
19. Cowden syndrome-associated germline SDHD variants alter PTEN nuclear translocation through src-induced PTEN oxidation.
Yu W; He X; Ni Y; Ngeow J; Eng C
Hum Mol Genet; 2015 Jan; 24(1):142-53. PubMed ID: 25149476
[TBL] [Abstract] [Full Text] [Related]
20. Combined BRAF(V600E)- and src-inhibition induces apoptosis, evokes an immune response and reduces tumor growth in an immunocompetent orthotopic mouse model of anaplastic thyroid cancer.
Vanden Borre P; Gunda V; McFadden DG; Sadow PM; Varmeh S; Bernasconi M; Parangi S
Oncotarget; 2014 Jun; 5(12):3996-4010. PubMed ID: 24994118
[TBL] [Abstract] [Full Text] [Related]
[Next]
